Insmed | INSM - Creditori Commerciali

Prezzo Delle Azioni
136.00
Cambio Giornaliero
-8.00 -5.56%
Mensile
-14.48%
Annuale
70.17%
Q1 Previsione
131.92




Creditori Commerciali Cambiamento Data
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Cytokinetics USD 105.62M 83.53M 2025-12
DBV Technologies USD 39.82M 972K 2025-09
Gilead Sciences USD 808M 226M 2025-09
Heron Therapeutics USD 8.99M 3.02M 2025-12
Insmed USD 79.91M 316K 2025-12
Novartis USD 4.46B 99M 2025-12
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
Vertex Pharmaceuticals USD 3.43B 600.9M 2025-12